Curaleaf Stock: Bull vs. Bear
Marijuana stocks, on balance, had a forgettable 2022. Growth investors largely shied away from the industry in response to sky-high inflation and soaring interest rates.
Making matters worse, early growing pains for the industry, such as oversupply, a stubbornly persistent black market, and ill-advised capital management moves, continued to weigh on companies' top and bottom lines in 2022. The net result is that most publicly traded marijuana equities took a sizable haircut last year.
The top multi-state operator (MSO) Curaleaf (OTC: CURLF), for instance, lost an eye-popping 52% of its value in 2022. Is this substantial pullback a buying opportunity, or should investors remain on the sidelines as the industry works through these various headwinds? Below is a bullish versus bearish take on Curaleaf's near-term prospects.
Source Fool.com
